Capital Investment Advisory Services LLC Takes $191,000 Position in Clorox Co (CLX)

Share on StockTwits

Capital Investment Advisory Services LLC acquired a new position in shares of Clorox Co (NYSE:CLX) in the 4th quarter, Holdings Channel reports. The fund acquired 1,240 shares of the company’s stock, valued at approximately $191,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Meeder Asset Management Inc. acquired a new stake in Clorox in the fourth quarter valued at $26,000. City Holding Co. raised its holdings in Clorox by 150.0% in the fourth quarter. City Holding Co. now owns 250 shares of the company’s stock valued at $39,000 after acquiring an additional 150 shares in the last quarter. G&S Capital LLC raised its holdings in Clorox by 46.4% in the fourth quarter. G&S Capital LLC now owns 262 shares of the company’s stock valued at $40,000 after acquiring an additional 83 shares in the last quarter. Sonora Investment Management LLC acquired a new stake in Clorox in the fourth quarter valued at $50,000. Finally, Ipswich Investment Management Co. Inc. acquired a new stake in Clorox in the fourth quarter valued at $73,000. Institutional investors own 82.60% of the company’s stock.

Shares of NYSE:CLX opened at $155.66 on Monday. The firm has a market cap of $19.95 billion, a price-to-earnings ratio of 25.73, a price-to-earnings-growth ratio of 3.86 and a beta of 0.29. Clorox Co has a 1-year low of $113.57 and a 1-year high of $167.70. The company has a debt-to-equity ratio of 3.08, a quick ratio of 0.66 and a current ratio of 1.15.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 4th. The company reported $1.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.32 by $0.08. The company had revenue of $1.47 billion for the quarter, compared to analysts’ expectations of $1.47 billion. Clorox had a net margin of 12.65% and a return on equity of 105.97%. The firm’s revenue was up 4.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.77 earnings per share. As a group, equities research analysts anticipate that Clorox Co will post 6.33 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, February 8th. Shareholders of record on Wednesday, January 23rd were issued a dividend of $0.96 per share. The ex-dividend date of this dividend was Tuesday, January 22nd. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.47%. Clorox’s dividend payout ratio (DPR) is 61.34%.

In other Clorox news, SVP Michael R. Costello sold 6,882 shares of the stock in a transaction on Thursday, November 15th. The shares were sold at an average price of $160.08, for a total transaction of $1,101,670.56. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Benno O. Dorer sold 152,449 shares of the stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $164.83, for a total transaction of $25,128,168.67. Following the completion of the sale, the chief executive officer now directly owns 111,735 shares in the company, valued at approximately $18,417,280.05. The disclosure for this sale can be found here. Insiders have sold 256,728 shares of company stock worth $41,973,324 over the last three months. 1.40% of the stock is owned by corporate insiders.

Several analysts recently issued reports on CLX shares. BMO Capital Markets upped their price target on shares of Clorox from $153.00 to $165.00 and gave the company a “buy” rating in a report on Friday, November 2nd. Citigroup upped their price target on shares of Clorox from $153.00 to $169.00 and gave the company a “hold” rating in a report on Tuesday, November 20th. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating in a report on Monday, November 19th. Barclays set a $138.00 price target on shares of Clorox and gave the company a “hold” rating in a report on Thursday, November 1st. Finally, Wells Fargo & Co reaffirmed a “hold” rating on shares of Clorox in a report on Wednesday, October 31st. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. Clorox has an average rating of “Hold” and a consensus price target of $149.08.

COPYRIGHT VIOLATION WARNING: “Capital Investment Advisory Services LLC Takes $191,000 Position in Clorox Co (CLX)” was first posted by Macon Daily and is owned by of Macon Daily. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://macondaily.com/2019/02/11/capital-investment-advisory-services-llc-takes-191000-position-in-clorox-co-clx.html.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: Fundamental Analysis – How It Helps Investors

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply